// STATE LEGISLATION TRACKER

Illinois HB 1256: WORKERS COMP-COMPOUND DRUGS

⚖️ NEUTRAL for peptide users 👤 LOW user impact 📜 Status: In committee

State: Illinois
Bill: HB 1256
Filed: 2025-01-10
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Illinois HB1256 is a workers' compensation bill about payment rules for custom compounded drugs. It appears aimed at billing controls, including ingredient-level pricing and limits on longer supplies unless preauthorized, not at general peptide prescribing or patient-paid peptide access.

Key Points

Applies to workers' compensation drug payment, not ordinary cash-pay peptide care
Targets custom compounded medications, so peptide compounds could matter only in work-injury claims
Would require more detailed billing tied to component drugs and NDCs
Allows a one-time 7-day supply unless a longer fill is preauthorized
Does not appear to change telehealth, NP/naturopath scope, 503A/503B rules, or PDMP rules

What to Watch For

Concern If a compounded peptide is billed through workers' comp, longer fills could face preauthorization friction.

Note This looks like a reimbursement-control bill, not a broad compounding or peptide-access bill.

Note No clear effect on off-label prescribing, telehealth clinics, controlled substances, or FDA 503A/503B standards.

Where the Bill Stands

The bill was filed and referred to the Illinois House Rules Committee on January 28, 2025, with no later movement found from the available sources.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-10-02 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws